Zomedica Profit Margin

The latest profit margin for ZOM is -51.39% as of June 2026. That compares with -300.11% in the prior-year period — up 82.9% year over year. That is below the Healthcare sector average of 13.76%. Investors often review this figure alongside Zomedica's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZOM's profit margin moved from -300.11% to -51.39% — a 82.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zomedica's valuation or profitability profile.

Against Healthcare companies, ZOM currently prints -51.39% for profit margin, while the sector average sits near 13.76%. That is roughly 473.4% below the sector mean. Large gaps often invite a closer look at Zomedica's growth, margins, and balance sheet.

Profit Margin shows how effectively Zomedica converts resources into returns. At -51.39%, ZOM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -300.11% in the prior-year period — up 82.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ZOM's profit margin (-51.39%), review year-over-year change from -300.11%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.